Stay updated on Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Advanced Melanoma Clinical Trial page
- Check5 days agoChange DetectedA new site revision entry v3.5.4 has been added to the history, and the prior v3.5.3 entry has been removed. This update reflects backend versioning changes without affecting visible studies or data.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe page header/footer software revision indicator was updated from **v3.5.0** to **v3.5.3**, reflecting a version change in the ClinicalTrials.gov interface/system.SummaryDifference0.0%

- Check63 days agoChange DetectedThe Record History page shows a new revision label (v3.5.0) and removes the previous revision (v3.4.3), indicating a system version update rather than changes to study content.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page header.SummaryDifference0.0%

- Check99 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; the study record content and history listing appear unchanged.SummaryDifference0.0%

- Check106 days agoChange DetectedThe revision history now shows a new latest revision, v3.4.1, and removes the previous revision, v3.4.0.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.